Ms Kati Mayer, DPT | |
10008 Walnut Dr., #202, Kansas City, MO 64114 | |
(479) 685-6768 | |
Not Available |
Full Name | Ms Kati Mayer |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 10008 Walnut Dr., Kansas City, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013339753 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 2013028662 (Missouri) | Primary |
Provider Name | Bloomfield Physical Therapy |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1043860166 PECOS PAC ID: 2264763598 Enrollment ID: O20201013000008 |
News Archive
A new study on how alcohol relapse affects survival rates after liver transplants found that it adversely affected survival rates only after 10 years. The decrease in survival rates may, however, be due to other alcohol-related diseases.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
Adults who report having had higher exposure to infant siblings during their first 6 years of life have a reduced risk of multiple sclerosis (MS), according to a study in the January 26 issue of JAMA.
A House panel heard testimony from officials from five states - Hawaii, Maryland, Massachusetts, Minnesota and Oregon - that faced problems during the health law's open enrollment period and from California, which has had success.
"European policy makers were urged Wednesday to find viable financial incentives to get drug companies to discover new antibiotics, because the lack of fresh supplies poses acute dangers to health care and efforts against infectious diseases," according to a report by the Office of Health Economics and funded by GlaxoSmithKline, Dow Jones/Wall Street Journal reports.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Kati Mayer, DPT 10008 Walnut Dr., #202, Kansas City, MO 64114 Ph: (479) 685-6768 | Ms Kati Mayer, DPT 10008 Walnut Dr., #202, Kansas City, MO 64114 Ph: (479) 685-6768 |
News Archive
A new study on how alcohol relapse affects survival rates after liver transplants found that it adversely affected survival rates only after 10 years. The decrease in survival rates may, however, be due to other alcohol-related diseases.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
Adults who report having had higher exposure to infant siblings during their first 6 years of life have a reduced risk of multiple sclerosis (MS), according to a study in the January 26 issue of JAMA.
A House panel heard testimony from officials from five states - Hawaii, Maryland, Massachusetts, Minnesota and Oregon - that faced problems during the health law's open enrollment period and from California, which has had success.
"European policy makers were urged Wednesday to find viable financial incentives to get drug companies to discover new antibiotics, because the lack of fresh supplies poses acute dangers to health care and efforts against infectious diseases," according to a report by the Office of Health Economics and funded by GlaxoSmithKline, Dow Jones/Wall Street Journal reports.
› Verified 1 days ago
Dr. Scott Lawrence Jones, DPT, MHA, OCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 912 W 78th St, Kansas City, MO 64114 Phone: 816-305-0030 | |
Paula Dianne Walsh, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 406 Armour Rd Ste 200, Kansas City, MO 64116 Phone: 816-895-9126 Fax: 816-895-5436 | |
Julie Musick, MS,PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3380 Fax: 816-346-1372 | |
Erin Leigh Mooney, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13157 State Line Rd, Kansas City, MO 64145 Phone: 816-941-2550 Fax: 816-941-2520 | |
Judith E Vinlove Hutchison, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6758 Pennsylvania Ave, Kansas City, MO 64113 Phone: 816-914-4868 | |
Sophie Dehaven, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4700 Belleview Ave Ste 415, Kansas City, MO 64112 Phone: 816-569-2802 |